Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis
Authors:
- 12 April 2007
- journal article
- case report
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 52 (11) , 3123-3135
Abstract
Primary sclerosing cholangitis (PSC) can lead to the development of cholangiocarcinoma (CCA). The tumor may present as an intrahepatic focal cholangiocellular carcinoma but more often as a ductal infiltrating desmoplastic lesion. CCA is found synchronously with the diagnosis of PSC in 20–30% and within 1 year in 50%. During later follow-up, the yearly developmental rate of CCA is 0.5–1.5%. Most patients with PSC and CCA do not yet have cirrhosis but present with a severe stenosis at the hilum of the liver. This type of tumor is difficult to diagnose by imaging techniques.18F-FDG-PET scanning and CEA or CA 19-9 are not early diagnostic tools. Regular MRI, multislice CT, and repeated endoscopically obtained brush cytology of stenotic lesions are recommended. The recent use of more extensive surgical resection techniques in patients with CCA results in 5-year survival rates of ≥50%. If tumors are small or incidental findings, liver transplantation leads to a 3- to 5-year survival rate of 35%. Pretransplant radiotherapy with 5-FU chemosensitization followed by endoscopic brachytherapy with iridium-192 seems to greatly improve the outcome of transplantation. Treatment with ursodeoxycholic acid may prevent development of CCA.Keywords
This publication has 97 references indexed in Scilit:
- Magnitude of Combination Therapy of Radical Resection and External Beam Radiotherapy for Patients With Carcinomas of the Extrahepatic Bile Duct and GallbladderDigestive Diseases and Sciences, 2005
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005
- Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancyJournal of Hepatology, 2004
- Hepatectomy With Portal Vein Resection for Hilar CholangiocarcinomaAnnals of Surgery, 2003
- Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitisJournal of Hepatology, 2000
- p53 overexpression and K- ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experienceJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- One hundred and eleven liver resections for hilar bile duct cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Surgery for hilar cholangiocarcinoma: the Johns Hopkins approachJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Risk factors in primary sclerosing cholangitisJournal of Hepatology, 1994